Warsaw Medical Innovation CenterS.A.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2023-08-11
Share capital
110,000.00 PLN
Registered address
ul. Béli Bartóka 8/25, 02-787 Warszawa, Poland
Website
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Spółka wykazała stratę, ale walne zgromadzenie i zarząd podjęły decyzję o kontynuowaniu działalności; planowane jest zwiększenie dochodów z usług i wsparcie inwestorów strategicznych.
From the notes
| Profit allocation | Loss to be covered |
Filing timeliness
3 of 3 financial statements were filed late (the longest delay 136 days for 2023). All were audited by a statutory auditor.
- 202507/09/2026
- 202406/08/2025
- 202328/11/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Piotr Stanisław Fiedor – President of the Management Board
Manner of representation
Authorized to make declarations of will and sign on behalf of the company are the members of the management board acting jointly.
Supervisory board
Agnieszka Juszkiewicz – Supervisory Board Member
Artur Bartoszewicz – Supervisory Board Member
Piotr Tomasz Stark – Supervisory Board Member
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-05-06.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| InventroS.A. | $12,176.61 | inventro.co | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-12-12 | Address change (Ul. Poborzańska 25, 03-368, Warszawa → Ul. Béli Bartóka 8/25, 02-787, Warszawa) | |
| 2024-12-12 | Share capital increase (100,000.00 PLN → 110,000.00 PLN) | |
| 2024-05-27 | Address change (Ul. Ludwika Zamenhofa 7/4, 00-165, Warszawa → Ul. Poborzańska 25, 03-368, Warszawa) | |
| 2023-08-11 | Entered in the register |
FAQ
The main business activity of Warsaw Medical Innovation Center focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 11, 2023.
The headquarters is located at: ul. Béli Bartóka 8, 02-787 Warszawa.
The management board consists of: Piotr Stanisław Fiedor (President of the Management Board).
The share capital of the company is PLN 110,000 (approx. $29,714).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company's revenue reached USD 17,539.
No, in 2024 the company was not profitable, reporting a net loss of USD 66,440. For comparison, in 2023 the loss was USD 69,523, meaning the company reduced its loss by 9.2%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 53,843 in 2024, representing 64% of all operating expenses.
Last updated: 2026-10-03